114 related articles for article (PubMed ID: 25895998)
1. Using RNA nanoparticles with thermostable motifs and fluorogenic modules for real-time detection of RNA folding and turnover in prokaryotic and eukaryotic cells.
Zhang H; Pi F; Shu D; Vieweger M; Guo P
Methods Mol Biol; 2015; 1297():95-111. PubMed ID: 25895998
[TBL] [Abstract][Full Text] [Related]
2. Fluorogenic RNA nanoparticles for monitoring RNA folding and degradation in real time in living cells.
Reif R; Haque F; Guo P
Nucleic Acid Ther; 2012 Dec; 22(6):428-37. PubMed ID: 23113765
[TBL] [Abstract][Full Text] [Related]
3. Functional assays for specific targeting and delivery of RNA nanoparticles to brain tumor.
Lee TJ; Haque F; Vieweger M; Yoo JY; Kaur B; Guo P; Croce CM
Methods Mol Biol; 2015; 1297():137-52. PubMed ID: 25896001
[TBL] [Abstract][Full Text] [Related]
4. Assembly of multifunctional phi29 pRNA nanoparticles for specific delivery of siRNA and other therapeutics to targeted cells.
Shu Y; Cinier M; Shu D; Guo P
Methods; 2011 Jun; 54(2):204-14. PubMed ID: 21320601
[TBL] [Abstract][Full Text] [Related]
5. Programmable folding of fusion RNA in vivo and in vitro driven by pRNA 3WJ motif of phi29 DNA packaging motor.
Shu D; Khisamutdinov EF; Zhang L; Guo P
Nucleic Acids Res; 2014 Jan; 42(2):e10. PubMed ID: 24084081
[TBL] [Abstract][Full Text] [Related]
6. Fabrication of pRNA nanoparticles to deliver therapeutic RNAs and bioactive compounds into tumor cells.
Shu Y; Shu D; Haque F; Guo P
Nat Protoc; 2013 Sep; 8(9):1635-59. PubMed ID: 23928498
[TBL] [Abstract][Full Text] [Related]
7. Methods for construction and characterization of simple or special multifunctional RNA nanoparticles based on the 3WJ of phi29 DNA packaging motor.
Guo S; Piao X; Li H; Guo P
Methods; 2018 Jul; 143():121-133. PubMed ID: 29530505
[TBL] [Abstract][Full Text] [Related]
8. Fabrication of 14 different RNA nanoparticles for specific tumor targeting without accumulation in normal organs.
Shu Y; Haque F; Shu D; Li W; Zhu Z; Kotb M; Lyubchenko Y; Guo P
RNA; 2013 Jun; 19(6):767-77. PubMed ID: 23604636
[TBL] [Abstract][Full Text] [Related]
9. Using Planar Phi29 pRNA Three-Way Junction to Control Size and Shape of RNA Nanoparticles for Biodistribution Profiling in Mice.
Haque F; Xu C; Jasinski DL; Li H; Guo P
Methods Mol Biol; 2017; 1632():359-380. PubMed ID: 28730451
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, conjugation, and labeling of multifunctional pRNA nanoparticles for specific delivery of siRNA, drugs, and other therapeutics to target cells.
Guo P; Shu Y; Binzel D; Cinier M
Methods Mol Biol; 2012; 928():197-219. PubMed ID: 22956144
[TBL] [Abstract][Full Text] [Related]
11. Thermodynamically stable RNA three-way junction for constructing multifunctional nanoparticles for delivery of therapeutics.
Shu D; Shu Y; Haque F; Abdelmawla S; Guo P
Nat Nanotechnol; 2011 Sep; 6(10):658-67. PubMed ID: 21909084
[TBL] [Abstract][Full Text] [Related]
12. RNA self-assembly and RNA nanotechnology.
Grabow WW; Jaeger L
Acc Chem Res; 2014 Jun; 47(6):1871-80. PubMed ID: 24856178
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of three-component collision to produce ultrastable pRNA three-way junction of Phi29 DNA-packaging motor by kinetic assessment.
Binzel DW; Khisamutdinov E; Vieweger M; Ortega J; Li J; Guo P
RNA; 2016 Nov; 22(11):1710-1718. PubMed ID: 27672132
[TBL] [Abstract][Full Text] [Related]
14. Current advances in Phi29 pRNA biology and its application in drug delivery.
Ye X; Hemida M; Zhang HM; Hanson P; Ye Q; Yang D
Wiley Interdiscip Rev RNA; 2012; 3(4):469-81. PubMed ID: 22362726
[TBL] [Abstract][Full Text] [Related]
15. Targeted delivery of small noncoding RNA for glioblastoma.
Yoo JY; Yeh M; Kaur B; Lee TJ
Cancer Lett; 2021 Mar; 500():274-280. PubMed ID: 33176185
[TBL] [Abstract][Full Text] [Related]
16. Single-Molecule Approaches for the Characterization of Riboswitch Folding Mechanisms.
Boudreault J; Perez-Gonzalez DC; Penedo JC; Lafontaine DA
Methods Mol Biol; 2015; 1334():101-7. PubMed ID: 26404145
[TBL] [Abstract][Full Text] [Related]
17. Physicochemically tunable polyfunctionalized RNA square architecture with fluorogenic and ribozymatic properties.
Jasinski DL; Khisamutdinov EF; Lyubchenko YL; Guo P
ACS Nano; 2014 Aug; 8(8):7620-9. PubMed ID: 24971772
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of chemically synthesized monomeric phi29 pRNA nanoparticles for systemic delivery.
Abdelmawla S; Guo S; Zhang L; Pulukuri SM; Patankar P; Conley P; Trebley J; Guo P; Li QX
Mol Ther; 2011 Jul; 19(7):1312-22. PubMed ID: 21468004
[TBL] [Abstract][Full Text] [Related]
19. Bottom-up assembly of RNA nanoparticles containing phi29 motor pRNA to silence the asthma STAT5b gene.
Qiu C; Peng WK; Shi F; Zhang T
Genet Mol Res; 2012 Sep; 11(3):3236-45. PubMed ID: 23079817
[TBL] [Abstract][Full Text] [Related]
20. RNA-based networks: using RNA aptamers and ribozymes as synthetic genetic devices.
Weigand JE; Wittmann A; Suess B
Methods Mol Biol; 2012; 813():157-68. PubMed ID: 22083741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
